Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Blood Pressure Monitoring|September 30, 2024
Serum uric acid-lowering effect of sacubitril/valsartan in hypertensive patients: evaluation by switching from angiotensin II receptor blockersTakeshi Horio, Yoshio Iwashima, Minoru Yoshiyama, et al.Circulation Reports|July 11, 2024
Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive EffectTakeshi Horio, Yoshio Iwashima, Minoru Yoshiyama, et al.International Journal of Clinical Pharmacology and Therapeutics|August 7, 2023
Differential effects on renal function and glucose metabolism of renal dependent bezafibrate and non-renal dependent pemafibrate in patients with hypertriglyceridemiaMana Nishida, Takeshi Horio, Yusuke Fukuda, et al.Experimental Neurology|December 13, 2005
Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic ratsTakamasa Hasegawa, Atsushi Kosaki, Kiyoshi Shimizu, et al.JMA Journal|February 28, 2022
Acromegaly Initially Presenting with Severe Infectious Diseases: A Case ReportEriko Tani, Tomonori Hirashima, Takamasa Hasegawa, et al.Kidney & Blood Pressure Research|March 3, 2005
Comparison of the effects of quinapril and losartan on carotid artery intima-media thickness in patients with mild-to-moderate arterial hypertensionYoko Uchiyama-Tanaka, Yasukiyo Mori, Noriko Kishimoto, et al.Atherosclerosis|December 4, 2003
The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophagesTakamasa Hasegawa, Atsushi Kosaki, Tatsuji Kimura, et al.The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetesAtsushi Kosaki, Takamasa Hasegawa, Tatsuji Kimura, et al.Pageof 1